Tomasello A, Moreu M, Terceño M, Dinia L, Barrena Caballo MR, Requena M, Jablonska M, Cendrero J, Flores A, Ortega S, Diana F, Henandez D, de Dios M, Rubiera M, Garcia-Tornel A, Rizzo F, Olivé M, Pérez-García C, Trejo Gallego C, Carmona T, Rodrigo-Gisbert M, Molina C, Ribo M
Randomized Study Comparing First-Line Dual Versus Single-Stent Retriever Technique: TWIN2WIN.
Rofes, P, Castillo-Manzano, C, Menéndez, M, Teulé, A, Iglesias, S, Munté, E, Ramos-Muntada, M, Gómez, C, Tornero, E, Darder, E, Montes, E, Valle, L, Capellá, G, Pineda, M, Brunet, J, Feliubadaló, L, del Valle, J, Lázaro, C
<i>TP53</i> germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate
Gómez-Vilarrubla, A, Niubó-Pallàs, M, Mas-Parés, B, Bonmati-Santané, A, Martínez-Calcerrada, JM, López, B, Peñas-Cruz, A, de Zegher, F, Ibáñez, L, López-Bermejo, A, Bassols, J
Longitudinal Analysis of Placental IRS1 DNA Methylation and Childhood Obesity
Manubens A, Paiva B, Gutiérrez NC, Fernandez M, Calasanz MJ, Rosiñol L, Oriol A, Blanchard MJ, Carrillo E, Benavente C, Martínez-López J, Bargay J, Hernández MT, de la Rubia J, González Y, Paricio M, de Arriba F, Ocio EM, Teruel AI, de la Guia AL, Sirvent M, Gironella M, Sampol A, Arguiñano JM, Cabrera C, Alegre A, Granell M, Cabañas V, Núñez-Córdoba JM, Mateos MV, Lahuerta JJ, San Miguel JF, Bladé J, Rodriguez-Otero P
High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy.
Ausellé-Bosch, S, Pardo, M, Pareja, M, Polonio-Alcalá, E, Puig, T
Screening of electrospun PS/PCL scaffolds for three-dimensional triple negative breast cancer cell culture: impact of solvent, hydrophobicity, and setup orientation
Ssenyonga, N, Stiller, CA, Marcos-Gragera, R, Kuehni, CE, Saint-Jacques, N, Bulliard, JL, Redaniel, MT, Nakata, K, Schwartz, S, De, P, Ragusa, R, Troussard, X, Curado, MP, Girardi, F, Maynadié, M, Valkov, M, Guilloteau, A, Lima, C, Coleman, MP, Allemani, C
Conditional survival of children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 world-wide: (CONCORD-3)
Garcia-Sarreon, A, Quiroga-Varela, A, Gifreu, A, Lago, AB, Gutierrez, J, Gonzalez-Platas, M, Pons, JH, Benavides, AM, Coll-Martinez, C, Fulla, JG, Bravo, GA
Association of Human Leukocyte Antigens with Idiopathic Neuroimmunological Conditions
Castaño-Díez S, López-Guerra M, Zugasti I, Calvo X, Schulz FI, Avendaño A, Mora E, Falantes-González JF, Azaceta G, Ibañez M, Chen-Liang TH, Notario Mc Donnell C, Amer-Salas N, Palomo L, Pomares H, Vila J, Bernal Del Castillo T, Jiménez-Vicente C, Esteban D, Guijarro F, Álamo Moreno JR, Cortés-Bullich A, Torrecillas-Mayayo V, Triguero A, Mont-de Torres L, Carcelero E, Cardús A, Germing U, Betz B, Rozman M, Arenillas L, Zamora L, Díez-Campelo M, Xicoy B, Esteve J, Díaz-Beyá M
AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification.
Bosch-Barrera J, Estévez-García P, Martín-Martorell P, Sabatier R, Nadal E, Sais E, Gascón P, Oaknin A, Rodon J, Lizcano JM, Muñoz-Guardiola P, Fierro-Durán G, Pedrós-Gámez O, Pérez-Montoyo H, Yeste-Velasco M, Cortal M, Pérez-Campos A, Alfón J, Domènech C, Morán T
ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer.
Díaz-Cutraro, L, Verdaguer-Rodríguez, M, García-Mieres, H, Ferrer-Quintero, M, López-Carrilero, R, Palma-Sevillano, C, Lamarca, M, Espinosa, V, Barrigón, ML, González-Higueras, F, Pousa, E, Grasa, E, Lorente-Rovira, E, Gutiérrez-Zotes, A, Barajas, A, Ruiz-Delgado, I, Cid, J, Moritz, S, Rico, J, Sevilla-Llewellyn-Jones, J, Haro, JM, Ochoa, S
Sex-based differences in Jumping to Conclusions: a multidimensional analysis of first-episode psychosis
Alsina M, Villacampa G, de Andrea C, Vivancos A, Ponz-Sarvise M, Arrazubi V, Jimenez-Fonseca P, Diez M, Sanz-Garcia E, Martínez E, Guardeño R, Calvo M, Bugés C, Longo F, Navarro V, García-Galea E, Gros A, Ochoa MC, Lopez-Janeiro A, Sanchez-Gregorio S, Herrero C, Labiano I, Vila-Casadesús M, López D, Alexandru R, Muñoz S, Tabernero J, Melero I
Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study.
Barretina-Ginesta, MP, Gil-Martin, M, Vaswani, AR, Sanchez-Heras, AB, Churruca, C, Guerra-Alía, EM, Madroñal, C, Fernández-Plana, J, Herrero, A, Dotor, E, Esteban, C, Quindós, M, Romeo, M, Gost, E, Bermejo, MJ, Fernandez-Chacón, C, Ferrer, N, Gómez-Raposo, C, Catot, S, Madariaga, A
Addressing Unmet Aftercare Needs In Long-Term Survivors Of Ovarian Cancer: Insights From A Spanish Cohort Of The ENGOTOv40/GEICO 71-R/Expression VI Survey
Sánchez Cánovas M, López Robles J, García Verdejo FJ, Cacho Lavin D, Olivares H, Garrido Fernández A, Coma Salvans E, Quintanar Verduguez T, Salvador Coloma C, Fernández Garay D, Cumplido JD, Ferrer Pérez AI, Carbó Bagué A, Teigell Muñoz FJ, García López R, Martínez Marin A, Muñoz Martín AJ
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.
Sol, J, Fernàndez-Bernal, A, Mota-Martorell, N, Martín-Garí, M, Obis,É, Juanes, A, Ayala, V, Mayneris-Perxachs, J, Ramos, R, Pineda, V, Garre-Olmo, J, Portero-Otín, M, Fernández-Real, JM, Puig, J, Jové, M, Pamplona, R
Ether lipids and sphingolipids drive sex-specific human aging dynamics
